Chelation Therapy Has Been Approved — by the FDA as a Treatment for Lead Poisoning

Posted on Oct 24, 2008 in Heavy Metals

Chelation therapy is a natural way to detoxify the body of toxic chemical and harmful metals (heavy metal poisoning). Chelation therapy involves the injection of ethylene diamine tetraacetic acid (EDTA). It is a mean by which an organic substance (Edta) binds to minerals and ionized metals (electrically charged) such as iron, calcium, lead, copper, etc.

The first use of Chelation is in Germany in 1930. A decade later, EDTA (ethylene diamine tetraacetic) was used by some American workers suffering from lead poisoning. After many medical studies, in 1950, Dr. Norman Clarke, director of Providence Hospital in Detroit, Michigan, noted the treatment with EDTA can improve or restore health from many diseases. These improvements include, but are not limited to reduction in angina pain, decrease skin diseases, loss and keeping a normal weight, decrease in heart disease, improving memory faculties and urgency of the senses (sight, hearing, smell), increased energy, etc.

In USA, Chelation therapy with EDTA has been approved by the FDA as a treatment for lead poisoning only. However, since heavy metals poisoning can be responsible for major diseases, in alternative therapy, it is used to treat heart disease, cancer, gangrene, thyroid disorders, multiple sclerosis, muscular dystrophy, psoriasis, diabetes, arthritis, Alzheimer’s disease, and the improvement of memory, sight, hearing, and smell.

Chelation therapy and the Conventional Medicine

In addition to the detoxification of the body, recent scientific studies in the conventional medicine confirm the positive effects of chelation therapy in the treatment of cardiovascular diseases. However, this discovery is yet refuted by many scientists. In 2003, National Institutes of Health (NIH) has decided to undertake a comprehensive study for five years to assess the effectiveness of chelation therapy in more than 2 500 people surviving a heart attack. Since we are in 2008, the last year of this study, very soon, we will have the result. In the meantime, many patients continue to claim the benefits of chelation therapy in their life.

Chelation therapy and cancer

According to Journal of Advancement in Medicine, “Mortality from cancer was reduced 90% during an 18-year follow-up of 59 patients treated with Calcium-EDTA. Only one of 59 treated patients (1.7%) died of cancer while 30 of 172 non treated control subjects (17.6%) died of cancer (P=0.002). Death from artherosclerosis was also reduced. Treated patients had no evidence of cancer at the time of entry into this study.” To learn more about chealtion therapy our chelation therapy website.